---
title: "Rapport Therapeutics, Inc. (RAPP.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/RAPP.US.md"
symbol: "RAPP.US"
name: "Rapport Therapeutics, Inc."
industry: "Pharmaceuticals"
---

# Rapport Therapeutics, Inc. (RAPP.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [www.rapportrx.com](https://www.rapportrx.com) |

## Company Profile

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein ...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -14.39 | 197/257 | - | - | - |
| PB | 2.75 | 106/257 | 2.82 | 2.15 | 1.30 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-20T05:00:00.000Z

Total Analysts: **10**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 9 | 90% |
| Overweight | 1 | 10% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 29.50 |
| Highest Target | 80.00 |
| Lowest Target | 40.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/RAPP.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/RAPP.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/RAPP.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.